New Study: Cough, Cold and Allergy (Hay Fever) Remedies in Slovenia

From: Fast Market Research, Inc.
Published: Wed Apr 15 2015

The largest consumer health category in Slovenia in 2014 was cough, cold and allergy (hay fever) remedies category, resulting in retail value sales of €23 million. Cough, colds and flu are common recurring illnesses amongst Slovenians, which is the main driver for the category’s performance and growth. Self-medication in the case of flu or colds is quite widespread amongst consumers; moreover, even when they visit a doctor with such conditions, self-medication will be advised. Therefore, growth in combination products, cough remedies and decongestants is an expected outcome.

Full Report Details at

Competitive Landscape

Cough, cold and allergy (hay fever) remedies is rather competitive. However, three major market players with cumulative retail value share of 63% dominated the category. The leading company in this category in 2014 was Krka dd Novo Mesto with value share of 26%. The company during the review period was slightly losing its share, which is mainly explained by tough competition in the market. The most popular products from Krka in this category in 2014 remained Daleron Cold 3, Septolete and Panatus Forte. The second place in the category in 2014 was taken by Lek dd with retail value share of 24%. Contrary to Krka, Lek managed to increase its market share during the review period, mainly due to strong and successful advertising campaigns. The best-selling Lek products are Lekadol Plus C, Angal and Fluimikan. The third leading market player in 2014 with retail value share of 12% was Bayer Pharma with its widely known Bayer Aspirin Plus C product. Bayer saw marginal decline in 2014 compared to the previous year, mainly due to strong competition from Lek’s Lekadol Plus C product.

Industry Prospects

The cough, cold and allergy (hay fever) remedies category is expected to see further growth during the forecast period and is expected to be influenced by the same factors as those observed in the review period. The increasing number of people affected by different sorts of allergy in Slovenia is expected to contribute to the positive growth of antihistamines/allergy remedies (systemic), whilst stronger flu seasons and increasing incidence of colds are expected to drive demand for cough and cold remedies. Furthermore, according to ZZZS (public health insurance) data, the number of people getting influenza vaccination is on decline, due to the prevailing belief that it is not effective; thus the number of influenza cases is expected to increase over the forecast period.

Report Overview

Discover the latest market trends and uncover sources of future market growth for the Cough, Cold and Allergy (Hay Fever) Remedies industry in Slovenia with research from Euromonitor's team of in-country analysts.

About Fast Market Research

Fast Market Research is a leading distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff is always available to help you find the right research to fit your requirements and your budget.

For more information about these or related research reports, please visit our website at or call us at 1.800.844.8156 (1.413.485.7001 Int'l)

You may also be interested in these related reports:

- Cough, Cold and Allergy (Hay Fever) Remedies in South Korea
- Cough, Cold and Allergy (Hay Fever) Remedies in Ireland
- Cough, Cold and Allergy (Hay Fever) Remedies in Nigeria
- Cough, Cold and Allergy (Hay Fever) Remedies in Bosnia-Herzegovina
- Cough, Cold and Allergy (Hay Fever) Remedies in the United Arab Emirates

Company: Fast Market Research, Inc.
Contact Name: Bill Thompson
Contact Email:
Contact Phone: 1-413-485-7001

Visit website »